Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate

Journal of Periodontology

Volumn 84, Issue 6, 2013, Pages 749-757

  Döri, Ferenc ^a   Arweiler, Nicole B ^b   Szántó, Erika ^a   Ágics, Anikó ^a   Gera, István ^a   Sculean, Anton ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bone grafting; Enamel matrix proteins; Periodontitis; Randomized controlled trial; Regenerative medicine

Indexed keywords

BETA-TRICALCIUM PHOSPHATE; BIO OSS; BIO-OSS; CALCIUM PHOSPHATE; EDETIC ACID; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; MINERAL;

ADULT; AGED; ALVEOLAR BONE LOSS; ARTICLE; BONE MATRIX; BONE PROSTHESIS; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GINGIVA DISEASE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; SURGICAL FLAPS; TOOTH PLAQUE; TOOTH ROOT; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; ALVEOLAR BONE LOSS; BONE MATRIX; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CHRONIC PERIODONTITIS; DENTAL ENAMEL PROTEINS; DENTAL PLAQUE INDEX; EDETIC ACID; FEMALE; FOLLOW-UP STUDIES; GINGIVAL RECESSION; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; MALE; MIDDLE AGED; MINERALS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; ROOT PLANING; SURGICAL FLAPS; TOOTH ROOT; TREATMENT OUTCOME;

EID: 84878633042     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120238     Document Type: Article

References (46)

1. Sculean A, Alessandri R, Miron RJ, Salvi G, Bosshard DD. Enamel matrix proteins and periodontal wound healing and regeneration. Clin Adv Periodontics 2011; 1:101-117.
2. Bosshardt DD. Biological mediators and periodontal regeneration: A review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol 2008; 35(Suppl. 8):87-105.
3. Sculean A, Donos N, Brecx M, Reich E, Karring T. Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys. J Clin Periodontol 2000;27: 466-472.
4. Cochran DL, King GN, Schoolfield J, Velasquez-Plata D, Mellonig JT, Jones A. The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses. J Periodontol 2003;74:1043-1055.
5. Gkranias ND, Graziani F, Sculean A, Donos N. Wound healing following regenerative procedures in furcation degree III defects: Histomorphometric outcomes. Clin Oral Investig 2012;16:239-249.
6. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
7. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
8. Heijl L, Heden G, Svärdström G, Östgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
9. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001;72:25-34.
10. Chambrone D, Pasin IM, Chambrone L, Pannuti CM, Conde MC, Lima LA. Treatment of infrabony defects with or without enamel matrix proteins: A 24-month follow-up randomized pilot study. Quintessence Int 2010;41:125-134.
11. Jepsen S, Heinz B, Jepsen K, et al. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes. J Periodontol 2004; 75:1150-1160.
12. Spahr A, Haegewald S, Tsoulfidou F, et al. Coverage of Miller class I and II recession defects using enamel matrix proteins versus coronally advanced flap technique: A 2-year report. J Periodontol 2005;76:1871-1880.
13. Castellanos AT, de la Rosa MR, de la Garza M, Caffesse RG. Enamel matrix derivative and coronal flaps to cover marginal tissue recessions. J Periodontol 2006; 77:7-14.
14. Pilloni A, Paolantonio M, Camargo PM. Root coverage with a coronally positioned flap used in combination with enamel matrix derivative: 18-month clinical evaluation. J Periodontol 2006;77:2031-2039.
15. Sculean A, Schwarz F, Miliauskaite A, et al. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: An 8-year follow-up split-mouth study. J Periodontol 2006;77: 1879-1886.
16. Sculean A, Schwarz F, Chiantella GC, Arweiler NB, Becker J. Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: Report of 26 cases. Int J Periodontics Restorative Dent 2007;27:221-229.
17. Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2008;35: 817-824.
18. Harrel SK, Wilson TG Jr., Nunn ME. Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results. J Periodontol 2010;81:435-441.
19. Silvestri M, Rasperini G, Milani S. 120 infrabony defects treated with regenerative therapy: Long-term results. J Periodontol 2011;82:668-675.
20. Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int J Periodontics Restorative Dent 2008;28:153-161.
21. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 2000; 71:1110-1116.
22. Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:433-440.
23. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2003;74: 1725-1735.
24. GurinskyBS, MillsMP, Mellonig JT. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamelmatrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 2004;75:1309-1318.
25. Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L. Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 2007;78:231-238.
26. Yilmaz S, Cakar G, Yildirim B, Sculean A. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J Clin Periodontol 2010;37: 544-550.
27. Sculean A, Windisch P, Szendröi-Kiss D, et al. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 2008;79:1991-1999.
28. Sculean A, Pietruska M, Schwarz F, Willershausen B, Arweiler NB, Auschill TM. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study. J Clin Periodontol 2005;32:111-117.
29. Jepsen S, Topoll H, Rengers H, et al. Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: A multicentre randomized-controlled clinical trial. J Clin Periodontol 2008;35:420-428.
30. Pietruska M, Pietruski J, Nagy K, Brecx M, Arweiler NB, Sculean A. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. Clin Oral Investig 2012;16:1191-1197.
31. Trombelli L, Farina R. Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol 2008;35 (Suppl. 8):117-135.
32. Tu YK, Woolston A, Faggion CM Jr. Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomizedcontrolled trials. J Clin Periodontol 2010;37:59-79.
33. Miron RJ, Bosshardt D, Hedbom E, et al. Adsorption of enamel matrix proteins to a bovine-derived bone grafting material and its regulation of cell adhesion, proliferation, and differentiation. J Periodontol 2012; 83:936-947.
34. Saffar JL, Colombier ML, Detienville R. Bone formation in tricalcium phosphate-filled periodontal intrabony lesions. Histological observations in humans. J Periodontol 1990;61:209-216.
35. Stahl SS, Froum S. Histological evaluation of human intraosseous healing responses to the placement of tricalcium phosphate ceramic implants. I. Three to eight months. J Periodontol 1986;57:211-217.
36. Stavropoulos A, Windisch P, Szendröi-Kiss D, Peter R, Gera I, Sculean A. Clinical and histologic evaluation of granular beta-tricalcium phosphate for the treatment of human intrabony periodontal defects: A report on five cases. J Periodontol 2010;81:325-334.
37. Nevins M, Giannobile WV, McGuire MK, et al. Plateletderived growth factor stimulates bone fill and rate of attachment level gain: Results of a large multicenter randomized controlled trial. J Periodontol 2005;76: 2205-2215.
38. Stavropoulos A, Windisch P, Gera I, Capsius B, Sculean A, Wikesjö UM. A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/b-TCP for periodontal regeneration. J Clin Periodontol 2011;38:1044-1054.
39. Döri F, Arweiler N, Gera I, Sculean A. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. J Periodontol 2005;76:2236-2243.
40. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
41. Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol 1967;38:610-616.
42. Kim TS, Holle R, Hausmann E, Eickholz P. Long-term results of guided tissue regeneration therapy with nonresorbable and bioabsorbable barriers. II. A case series of infrabony defects. J Periodontol 2002;73:450-459.
43. Blomlöf JPS, Blomlöf LB, Lindskog SF. Smear removal and collagen exposure after non-surgical root planing followed by etching with an EDTA gel preparation. J Periodontol 1996;67:841-845.
44. Tonetti MS, Pini-Prato GP, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 1995;22:229-234.
45. Gunsolley JC, Elswick RK, Davenport JM. Equivalence and superiority testing in regeneration clinical trials. J Periodontol 1998;69:521-527.
46. Cortellini P, Tonetti MS. Long-term tooth survival following regenerative treatment of intrabony defects. J Periodontol 2004;75:672-678.